US Bancorp’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
Other funds holding XERS
RA
US Bancorp's XERS Position: Q2 2026 in Review
US Bancorp opened a new position in Xeris Biopharma Holdings (XERS) in Q2 2026: 30 shares worth $238. The stake represents ﹤0.01% of the portfolio and ranks #4100 among its holdings. This is a return to the name: US Bancorp previously reported a position in XERS as recently as Q1 2022.
US Bancorp first reported a position in XERS in Q1 2022 and has held it in 2 quarters since. The position peaked at $1K in Q1 2022. 240 funds tracked by Wall St. Rank hold XERS as of Q2 2026.
- US Bancorp held 30 shares of Xeris Biopharma Holdings worth $238 as of Q2 2026.
- Xeris Biopharma Holdings was a new US Bancorp position in Q2 2026.
- Xeris Biopharma Holdings made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #4100 holding.
- US Bancorp first reported a position in Xeris Biopharma Holdings in Q1 2022 and has held it in 2 quarters since.
- US Bancorp's Xeris Biopharma Holdings position peaked at $1K in Q1 2022.
- 240 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.
Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.